Biocytogen Pharmaceuticals (Beijing) Co., Ltd.: Biocytogen to Present Progress of Preclinical and Clinical Assets at BIO-EUROPE 2022

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) will present at the upcoming BIO-EUROPE conference in Leipzig, Germany on October 24-26 and virtually on November 2-4, 2022. Using

Related Keywords

Germany ,Beijing ,China ,Boston ,Massachusetts ,United States ,Heidelberg ,Baden Wüberg ,Shanghai ,Haimen Jiangsu ,Renmice Renmab Renlite ,Renmab Renlite ,Biocytogen Europe Innovation Center ,Chia Tai Tianqing Pharmaceutical Company ,Biocytogen Pharmaceuticals Beijing Co Ltd ,Biocytogen Pharmaceuticals ,Vivian Tian ,Project Integrum ,Merck Healthcare ,China Resources Biopharm ,Nanjing Chia Tai Tianqing Pharmaceutical Company ,Biocytogen ,Pharmaceuticals ,Present ,Progress ,Reclinical ,Linical ,Assets ,Europe ,022 ,